To include your compound in the COVID-19 Resource Center, submit it here.

Victrelis boceprevir regulatory update

FDA approved an NDA from Merck for Victrelis boceprevir plus standard of care - peginterferon alfa

Read the full 163 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE